Xie Jian 4
4 · Fulgent Genetics, Inc. · Filed May 28, 2026
Research Summary
AI-generated summary of this filing
Fulgent Genetics (FLGT) President/COO Xie Jian Sells Shares
What Happened
Xie Jian, President and COO of Fulgent Genetics, sold 1,201 shares on May 27, 2026, in open‑market transactions for a total of approximately $21,138. The reported weighted‑average price was $17.60 per share; individual sale prices ranged from $17.39 to $17.76. This was a sale (not a purchase) made to satisfy tax withholding on vested restricted stock units.
Key Details
- Transaction date: 2026-05-27; Form 4 filed 2026-05-28 (timely filing).
- Total shares sold: 1,201; weighted‑average price: $17.60; total value ≈ $21,138.
- Price range: $17.39–$17.76; reporting person can provide per‑trade details on request (footnote F2).
- Reason: Shares sold to satisfy tax withholding obligations from RSUs granted Feb 26, 2024 (footnote F1).
- Trust note: Some securities referenced are held by The Hsieh Family Dynasty Trust; Xie serves on its investment committee and disclaims beneficial interest except pecuniary (footnote F3).
- Transaction code: S = Sale.
Context
This was a routine sale to cover taxes on vested RSUs rather than a market-timed investment decision; such tax‑withholding sales are common and not necessarily a signal about the insider’s view of the company. The filing includes an undertaking to provide detailed per‑trade numbers and prices upon request.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-05-27$17.60/sh−1,201$21,138→ 369,751 total
- 220,816(indirect: By Trust)
Common Stock
[F3]
Footnotes (3)
- [F1]The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024.
- [F2]The shares were sold in multiple transactions at prices ranging from $17.39 to $17.76, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F3]Securities held by The Hsieh Family Dynasty Trust, dated January 27, 2010 (the "Trust"). Mr. Xie serves on the investment committee of the Trust. Mr. Xie disclaims any beneficial interest except with respect to any pecuniary interest therein.